Page last updated: 2024-12-05

scoparone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Scoparone is a coumarin derivative found in plants, particularly in the genus *Ruta*. It has been studied for its potential therapeutic properties, particularly in relation to its antioxidant, anti-inflammatory, and anticancer activities. The compound is known to exhibit inhibitory effects on various enzymes and cellular pathways involved in inflammation and cancer development. Researchers are exploring its potential for treating conditions such as arthritis, cardiovascular diseases, and neurological disorders. Scoparone is a natural product and has been explored for its medicinal properties for centuries. Its synthesis involves various methods, including extraction from plant sources and chemical synthesis.'

scoparone: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

scoparone : A member of the class of coumarins that is esculetin in which the two hydroxy groups at positions 6 and 7 are replaced by methoxy groups. It is a major constituent of the Chinese herbal medicine Yin Chen Hao, and exhibits a variety of pharmacological activities such as anti-inflammatory, anti-allergic, and anti-tumor activities. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID8417
CHEMBL ID325864
CHEBI ID9055
SCHEMBL ID240777
MeSH IDM0069409

Synonyms (71)

Synonym
scopoletin methyl ether
6,7-dimethylesculetin
esculetin dimethyl ether
scoparon
6,7-dimethoxy-2-benzopyrone
6,7-dimethoxybenzopyran-2-one
benzopyran-2-one, 6,7-dimethoxy-
einecs 204-369-0
escoparone
coumarin, 6,7-dimethoxy-
brn 0169572
6,7-dimethoxy-2h-1-benzopyran-2-one
aesculetin dimethyl ether
ACON1_002079
MEGXP0_001422
6,7-dimethoxy-coumarin
dimethyl esculetin
120-08-1
6,7-dimethoxycoumarin
scoparone
C09311
SR-01000631300-1
6,7-dimethoxycoumarin, 98%
MAYBRIDGE4_003009
HMS1529I17
AC-11197
AKOS000277541
BRD-K16835051-001-01-2
BRD-K16835051-001-02-0
6,7-dimethoxychromen-2-one
chebi:9055 ,
6,7-dimethylcoumarine
CHEMBL325864
6,7-dimethoxy-chromen-2-one
CCG-41207
bdbm50361374
h5841pdt4y ,
unii-h5841pdt4y
5-18-03-00204 (beilstein handbook reference)
FT-0603321
AM20020282
SCHEMBL240777
6,7-dimethoxy-2h-chromen-2-one
scoparone [inci]
o-methylscopoletin
esculetin 6,7-dimethyl ether
o-methylisoscopoletin
scoparone [mi]
o,o-dimethylesculetin
S3613
2h-1-benzopyran-2-one, 6,7-dimethoxy-
GUAFOGOEJLSQBT-UHFFFAOYSA-N
6,7-dimethoxy-2h-chromen-2-one #
AC-34006
Q-100099
DTXSID10152640
mfcd00006871
dimethylaesculetin
scoparin?
6,7-dimethoxy-benzopyran-2-one
benzopyran-2-one, 6,7-dimethoxy- (9ci)
HY-N0228
CS-0008271
BS-14810
scoparone,(s)
BCP11533
6,7-dimethoxycoumarin pound>>escoparone
Q15424761
A14856
STL193280
6,7-dimethylesculetin, 6,7-dimethoxycoumarin

Research Excerpts

Overview

Scoparone is an active and efficious ingredient of herbal medicine Artemisia capillaris Thunb. It has been used clinically in traditional Chinese medicine formula (e.g. Yinchenhao) Scopar one is a biologically active constituent isolated from Artemisia Capillaris.

ExcerptReferenceRelevance
"Scoparone is an active and efficious ingredient of herbal medicine Artemisia capillaris Thunb, which has been used clinically in traditional Chinese medicine formula (e.g. "( Scoparone as a therapeutic drug in liver diseases: Pharmacology, pharmacokinetics and molecular mechanisms of action.
Chen, X; Cui, B; Fan, X; Feng, H; Hui, Y; Lin, L; Mao, L; Sun, C; Wang, B; Wang, X; Yu, Q; Yu, Z; Zhang, J; Zhao, T; Zhao, X, 2020
)
3.44
"Scoparone is a natural bioactive compound in Chinese herbal medicines. "( Comparison of In Vitro Hepatic Scoparone 7-O-Demethylation between Humans and Experimental Animals.
Auriola, S; Fayyaz, A; Juvonen, RO; Makwinja, S; Raunio, H, 2018
)
2.21
"Scoparone is a biologically active constituent isolated from Artemisia capillaris and possesses a variety of pharmacological activities, such as anti-inflammatory, anti-tumor, anti-allergic and anti-cardiovascular activities. "( Scoparone attenuates angiotensin II-induced extracellular matrix remodeling in cardiac fibroblasts.
Fu, B; Ma, X; Mu, C; Su, Y; Yu, F, 2018
)
3.37
"Scoparone is a biologically active constituent isolated from Artemisia capillaris and possesses anti-inflammatory activity."( Scoparone prevents IL-1β-induced inflammatory response in human osteoarthritis chondrocytes through the PI3K/Akt/NF-κB pathway.
Cai, Y; Hu, S; Li, Y; Lu, C; Peng, K; Yang, Z, 2018
)
2.64
"Scoparone is an important constituent of Yinchenhao, and displayed bright prospects in hepatoprotective effect."( Urinary metabolic profiling of rat models revealed protective function of scoparone against alcohol induced hepatotoxicity.
Sun, H; Wang, X; Zhang, A, 2014
)
1.35
"Scoparone, which is a major constituent of Artemisia capillaries, has been identified as an anticoagulant, hypolipidemic, vasorelaxant, anti-oxidant and anti-inflammatory drug, and it is used for the traditional treatment of neonatal jaundice. "( Scoparone interferes with STAT3-induced proliferation of vascular smooth muscle cells.
Choi, SH; Jeon, JH; Kim, JK; Lee, IK; Oh, CJ; Park, S, 2015
)
3.3
"Scoparone is an important constituent of Yinchenhao (Artemisia annua L.), a famous Chinese medicinal plant, and has several known bioactivities, and displayed bright prospects in prevention and therapy of jaundice and liver disorders. "( Pharmacokinetics and tissue distribution study of scoparone in rats by ultraperformance liquid-chromatography with tandem high-definition mass spectrometry.
Sun, H; Wang, X; Yin, Q; Zhang, A, 2012
)
2.07
"Scoparone is an important constituent of Yinchenhao (Artemisia annua L.), a famous medicinal plant, and displayed bright prospects in the prevention and therapy of liver injury. "( Metabolomics study on the hepatoprotective effect of scoparone using ultra-performance liquid chromatography/electrospray ionization quadruple time-of-flight mass spectrometry.
Dou, S; Sun, H; Sun, W; Wang, P; Wang, X; Wu, X; Zhang, A, 2013
)
2.08
"Scoparone is a major component of the shoot of Artemisia capillaris (Compositae), which has been used for the treatment of hepatitis and biliary tract infection in oriental countries. "( Scoparone from Artemisia capillaris inhibits the release of inflammatory mediators in RAW 264.7 cells upon stimulation cells by interferon-gamma Plus LPS.
Baek, SH; Chai, KY; Chung, HT; Jang, SI; Kim, YJ; Kwak, GB; Kwak, KC; Kwon, TO; Lee, WY; Yun, YG, 2005
)
3.21
"Scoparone is a major component of the shoot of Artemisia capillaris (Compositae), which has been used for the treatment of hepatitis and biliary tract infection in oriental countries. "( Scoparone inhibits PMA-induced IL-8 and MCP-1 production through suppression of NF-kappaB activation in U937 cells.
Jang, SI; Kim, HJ; Kim, HY; Kim, YC; Kim, YJ; Lee, JC; You, YO; Yu, HH; Yun, YG, 2006
)
3.22

Effects

Scoparone has a wide range of pharmacological activities, especially antioxidant and lipid-lowering ones. It has an antiatherogenic action in hyperlipidaemic diabetic rabbits.

Scoparone (SCO) has a wide range of pharmacological activities, especially antioxidant and lipid-lowering ones. It is proposed as an indicator substrate for the assessment of P450 differentiation in vitro in rat.

ExcerptReferenceRelevance
"Scoparone (SCO) has a wide range of pharmacological activities, especially antioxidant and lipid-lowering ones. "( The effects of scoparone on alcohol and high-fat diet-induced liver injury revealed by RNA sequencing.
Cao, H; Gao, Y; He, H; Li, T; Lu, H; Novák, P; Wei, M; Yang, C; Yin, Y; Zhang, K, 2022
)
2.52
"Scoparone has an antiatherogenic action in hyperlipidaemic diabetic rabbits."( Morphological evidence for the antiatherogenic effect of scoparone in hyperlipidaemic diabetic rabbits.
Chen, YL; Huang, HC; Lee, YT; Weng, YI; Yu, YJ, 1994
)
1.98
"Scoparone (SCO) has a wide range of pharmacological activities, especially antioxidant and lipid-lowering ones. "( The effects of scoparone on alcohol and high-fat diet-induced liver injury revealed by RNA sequencing.
Cao, H; Gao, Y; He, H; Li, T; Lu, H; Novák, P; Wei, M; Yang, C; Yin, Y; Zhang, K, 2022
)
2.52
"Scoparone has been shown to ameliorate many forms of liver disease, and several underlying molecular mechanisms involved have been previously revealed. "( Scoparone improves hepatic inflammation and autophagy in mice with nonalcoholic steatohepatitis by regulating the ROS/P38/Nrf2 axis and PI3K/AKT/mTOR pathway in macrophages.
Deng, X; Jiang, Q; Li, G; Liu, B; Xin, S; Xu, K; Zhang, J; Zhang, N, 2020
)
3.44
"Scoparone has an antiatherogenic action in hyperlipidaemic diabetic rabbits."( Morphological evidence for the antiatherogenic effect of scoparone in hyperlipidaemic diabetic rabbits.
Chen, YL; Huang, HC; Lee, YT; Weng, YI; Yu, YJ, 1994
)
1.98
"2. Scoparone has been proposed as an indicator substrate for the assessment of P450 differentiation in vitro in rat."( Regioselective O-demethylation of scoparone (6,7-dimethoxycoumarin) to assess cytochrome P450 activities in vitro in rat. Effects of gonadal steroids and the involvement of constitutive P450 enzymes.
Mennes, WC; Nijmeijer, SM; Noordhoek, J; Rozema, AW; van Miert, AS; Witkamp, RF, 1993
)
1.08

Actions

Scoparone did not enhance the expression of either human BSEP or, surprisingly, UGT1A1. It did not affect cardiac output, left ventricular pressure orleft ventricular work in the isolated perfused heart.

ExcerptReferenceRelevance
"Scoparone did not enhance the expression of either human BSEP or, surprisingly, UGT1A1. "( Scoparone potentiates transactivation of the bile salt export pump gene and this effect is enhanced by cytochrome P450 metabolism but abolished by a PKC inhibitor.
Deng, R; Shi, D; Yan, B; Yang, D; Yang, J, 2011
)
3.25
"Scoparone was found to cause the increase in coronary flow and heart rate, but did not affect cardiac output, left ventricular pressure or left ventricular work in the isolated perfused heart."( The effect of scoparone, a coumarin derivative isolated from the Chinese crude drug Artemisiae capillaris flos, on the heart.
Fujimura, H; Katayama, T; Kobayashi, G; Matsuda, H; Yamahara, J, 1989
)
1.36

Treatment

Scoparone-treatment (5 mg kg-1 day-1, s.c.) significantly reduced the plasma lipid and lipoprotein cholesterol levels of the hyperlipidaemic diabetic rabbit to 73.3% of total cholesterol. Pretreatment with scopar one inhibited the calcium uptake and p38 mitogen-activated protein kinase (MAPK) activity.

ExcerptReferenceRelevance
"Scoparone-treatment (5 mg kg-1 day-1, s.c.) significantly reduced the plasma lipid and lipoprotein cholesterol levels of the hyperlipidaemic diabetic rabbit to 73.3% of total cholesterol, 48.3% of total triglyceride, 66.0% of VLDL cholesterol, 55.7% of LDL cholesterol and 79.5% of HDL cholesterol."( Protection by scoparone against the alterations of plasma lipoproteins, vascular morphology and vascular reactivity in hyperlipidaemic diabetic rabbit.
Chen, YL; Huang, HC; Jan, TR; Lee, CR; Lee, YT; Weng, YI, 1993
)
1.37
"Pretreatment with scoparone inhibited the calcium uptake and p38 mitogen-activated protein kinase (MAPK) activity."( Anti-allergic effects of scoparone on mast cell-mediated allergy model.
Choi, YH; Yan, GH, 2009
)
0.98

Toxicity

ExcerptReferenceRelevance
" A single toxic dose of CCl(4) (1."( Protective effects of coumarin and coumarin derivatives against carbon tetrachloride-induced acute hepatotoxicity in rats.
Atmaca, M; Deniz Obay, B; Ketani, A; Murat Bilgin, H; Ozekinci, S; Taşdemir, E, 2011
)
0.37

Pharmacokinetics

The findings indicated that the pharmacokinetic properties of scoparone and scopoletin were significantly different between the normal and ANIT-induced cholestasis rats. This suggested that the clinical application dosage should be adjusted according to the liver function of patients.

ExcerptReferenceRelevance
" Mean T(1/2) values showed that half-life was dosage independent."( Pharmacokinetics of a novel anti-asthmatic, scoparone, in the rabbit serum assessed by a simple HPLC method.
Fang, Y; Li, Z; Watanabe, Y, 2003
)
0.58
"0 Pharmacokinetic Software."( Determination and pharmacokinetics of 6,7-dimethoxycoumarin in rat plasma after intragastric administration of different decoctions of yinchenhao tang.
Gao, XX; Li, K; Li, YQ; Wang, Q; Yu, ZG, 2007
)
0.34
" A successful application of the developed HPLC analysis was demonstrated for the pharmacokinetic study of a Traditional Chinese Medicine formula of Yin Chen Hao Tang preparation."( Simultaneous determination of 6,7-dimethylesculetin and geniposide in rat plasma and its application to pharmacokinetic studies of Yin Chen Hao Tang preparation.
Cao, H; Liu, L; Lv, H; Sun, H; Sun, W; Wang, P; Wang, X, 2008
)
0.35
" The results indicated that the method established was suitable for the determination and pharmacokinetic study of columbianadin in rat plasma."( A simple RP-HPLC method for quantification of columbianadin in rat plasma and its application to pharmacokinetic study.
Yang, XW; Zhang, YB, 2010
)
0.36
" In healthy rats, the estimated pharmacokinetic parameters (i."( Simultaneous in vivo RP-HPLC-DAD quantification of multiple-component and drug-drug interaction by pharmacokinetics, using 6,7-dimethylesculetin, geniposide and rhein as examples.
Jiao, G; Sun, H; Sun, W; Wang, X; Yuan, Y; Zhang, A, 2012
)
0.38
" The aim of this study was to investigate the in vivo plasma pharmacokinetic and tissue distribution characteristics of scoparone after oral administration."( Pharmacokinetics and tissue distribution study of scoparone in rats by ultraperformance liquid-chromatography with tandem high-definition mass spectrometry.
Sun, H; Wang, X; Yin, Q; Zhang, A, 2012
)
0.84
" In this comprehensive review, we provide the first summary of the pharmacological effects and pharmacokinetic characteristics of scoparone, and discuss future research prospects."( Scoparone as a therapeutic drug in liver diseases: Pharmacology, pharmacokinetics and molecular mechanisms of action.
Chen, X; Cui, B; Fan, X; Feng, H; Hui, Y; Lin, L; Mao, L; Sun, C; Wang, B; Wang, X; Yu, Q; Yu, Z; Zhang, J; Zhao, T; Zhao, X, 2020
)
2.21
"A sensitive and rapid LC-MS/MS method was established to detect scoparone and its metabolite of scopoletin in rat plasma and then compare their plasma pharmacokinetic differences between the normal and ANITinduced cholestasis rats."( Comparative Pharmacokinetics of Scoparone and its Metabolite Scopoletin in Normal and ANIT-induced Intrahepatic Cholestatic Rats.
Deng, S; Huo, X; Jin, H; Shu, X; Sun, C; Tian, Q; Wang, Y; Wu, W; Xu, L; Yang, X; Zhao, Y, 2023
)
1.43
" Therefore, we studied the pharmacokinetic properties of scoparone and scopoletin in rats after a single oral administration with the above method."( Comparative Pharmacokinetics of Scoparone and its Metabolite Scopoletin in Normal and ANIT-induced Intrahepatic Cholestatic Rats.
Deng, S; Huo, X; Jin, H; Shu, X; Sun, C; Tian, Q; Wang, Y; Wu, W; Xu, L; Yang, X; Zhao, Y, 2023
)
1.44
"The findings indicated that the pharmacokinetic properties of scoparone and scopoletin were significantly different between the normal and ANIT-induced cholestasis rats, which suggested that the clinical application dosage of scoparone should be adjusted according to the liver function of patients."( Comparative Pharmacokinetics of Scoparone and its Metabolite Scopoletin in Normal and ANIT-induced Intrahepatic Cholestatic Rats.
Deng, S; Huo, X; Jin, H; Shu, X; Sun, C; Tian, Q; Wang, Y; Wu, W; Xu, L; Yang, X; Zhao, Y, 2023
)
1.43

Compound-Compound Interactions

ExcerptReferenceRelevance
" C(max) , AUC and Cl) of D, G and R, when administered with COC (a combination of D, G and R), were C(max) 16."( Simultaneous in vivo RP-HPLC-DAD quantification of multiple-component and drug-drug interaction by pharmacokinetics, using 6,7-dimethylesculetin, geniposide and rhein as examples.
Jiao, G; Sun, H; Sun, W; Wang, X; Yuan, Y; Zhang, A, 2012
)
0.38

Bioavailability

ExcerptReferenceRelevance
" Moreover, hepatic dysfunction might promote bioavailability of scoparone due to limited intrinsic clearance."( Scoparone as a therapeutic drug in liver diseases: Pharmacology, pharmacokinetics and molecular mechanisms of action.
Chen, X; Cui, B; Fan, X; Feng, H; Hui, Y; Lin, L; Mao, L; Sun, C; Wang, B; Wang, X; Yu, Q; Yu, Z; Zhang, J; Zhao, T; Zhao, X, 2020
)
2.24
" However, its bioavailability to the brain and potential central effects remain unexplored."( Neuropsychopharmacological profiling of scoparone in mice.
Budzyńska, B; El Sayed, NS; Gertsch, J; Kowalczyk, J; Kurach, Ł; Pellegata, D; Skalicka-Woźniak, K, 2022
)
0.99

Dosage Studied

ExcerptRelevanceReference
" Three dosage levels (1."( [Effects of scoparone on hemodynamics in anesthetized rabbits].
Huang, JC; Sun, AX; Wang, RX; Wang, XR, 1993
)
0.66
" Mean T(1/2) values showed that half-life was dosage independent."( Pharmacokinetics of a novel anti-asthmatic, scoparone, in the rabbit serum assessed by a simple HPLC method.
Fang, Y; Li, Z; Watanabe, Y, 2003
)
0.58
"The findings indicated that the pharmacokinetic properties of scoparone and scopoletin were significantly different between the normal and ANIT-induced cholestasis rats, which suggested that the clinical application dosage of scoparone should be adjusted according to the liver function of patients."( Comparative Pharmacokinetics of Scoparone and its Metabolite Scopoletin in Normal and ANIT-induced Intrahepatic Cholestatic Rats.
Deng, S; Huo, X; Jin, H; Shu, X; Sun, C; Tian, Q; Wang, Y; Wu, W; Xu, L; Yang, X; Zhao, Y, 2023
)
1.43
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (6)

RoleDescription
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
anti-inflammatory agentAny compound that has anti-inflammatory effects.
antilipemic drugA substance used to treat hyperlipidemia (an excess of lipids in the blood).
immunosuppressive agentAn agent that suppresses immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-cells or by inhibiting the activation of helper cells. In addition, an immunosuppressive agent is a role played by a compound which is exhibited by a capability to diminish the extent and/or voracity of an immune response.
antihypertensive agentAny drug used in the treatment of acute or chronic vascular hypertension regardless of pharmacological mechanism.
anti-allergic agentA drug used to treat allergic reactions.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
coumarins
aromatic etherAny ether in which the oxygen is attached to at least one aryl substituent.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
esculetin modification219
esculetin modification221

Protein Targets (3)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Beta-secretase 1Homo sapiens (human)IC50 (µMol)500.00000.00061.619410.0000AID637774
Induced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)IC50 (µMol)25.14000.00442.923510.0000AID1701173
Induced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)Ki9.54000.00101.46539.5400AID1701173
Collagenase ColHHathewaya histolyticaIC50 (µMol)0.02400.02400.02400.0240AID1852251
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (32)

Processvia Protein(s)Taxonomy
proteolysisBeta-secretase 1Homo sapiens (human)
membrane protein ectodomain proteolysisBeta-secretase 1Homo sapiens (human)
response to lead ionBeta-secretase 1Homo sapiens (human)
protein processingBeta-secretase 1Homo sapiens (human)
amyloid-beta formationBeta-secretase 1Homo sapiens (human)
amyloid precursor protein catabolic processBeta-secretase 1Homo sapiens (human)
positive regulation of neuron apoptotic processBeta-secretase 1Homo sapiens (human)
amyloid-beta metabolic processBeta-secretase 1Homo sapiens (human)
detection of mechanical stimulus involved in sensory perception of painBeta-secretase 1Homo sapiens (human)
prepulse inhibitionBeta-secretase 1Homo sapiens (human)
cellular response to copper ionBeta-secretase 1Homo sapiens (human)
cellular response to manganese ionBeta-secretase 1Homo sapiens (human)
presynaptic modulation of chemical synaptic transmissionBeta-secretase 1Homo sapiens (human)
signaling receptor ligand precursor processingBeta-secretase 1Homo sapiens (human)
cellular response to amyloid-betaBeta-secretase 1Homo sapiens (human)
amyloid fibril formationBeta-secretase 1Homo sapiens (human)
DNA damage responseInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
response to cytokineInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
cell fate determinationInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
negative regulation of autophagyInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
cellular homeostasisInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
positive regulation of apoptotic processInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
negative regulation of apoptotic processInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
protein transmembrane transportInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
extrinsic apoptotic signaling pathway in absence of ligandInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathwayInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
negative regulation of anoikisInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
negative regulation of extrinsic apoptotic signaling pathway in absence of ligandInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
activation of cysteine-type endopeptidase activity involved in apoptotic processInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
mitochondrial fusionInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
release of cytochrome c from mitochondriaInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damageInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (13)

Processvia Protein(s)Taxonomy
amyloid-beta bindingBeta-secretase 1Homo sapiens (human)
endopeptidase activityBeta-secretase 1Homo sapiens (human)
aspartic-type endopeptidase activityBeta-secretase 1Homo sapiens (human)
protein bindingBeta-secretase 1Homo sapiens (human)
peptidase activityBeta-secretase 1Homo sapiens (human)
beta-aspartyl-peptidase activityBeta-secretase 1Homo sapiens (human)
enzyme bindingBeta-secretase 1Homo sapiens (human)
protein serine/threonine kinase bindingBeta-secretase 1Homo sapiens (human)
protein bindingInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
protein transmembrane transporter activityInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
protein heterodimerization activityInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
BH3 domain bindingInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
channel activityInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
BH domain bindingInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (27)

Processvia Protein(s)Taxonomy
lysosomeBeta-secretase 1Homo sapiens (human)
endosomeBeta-secretase 1Homo sapiens (human)
early endosomeBeta-secretase 1Homo sapiens (human)
late endosomeBeta-secretase 1Homo sapiens (human)
multivesicular bodyBeta-secretase 1Homo sapiens (human)
endoplasmic reticulum lumenBeta-secretase 1Homo sapiens (human)
Golgi apparatusBeta-secretase 1Homo sapiens (human)
trans-Golgi networkBeta-secretase 1Homo sapiens (human)
plasma membraneBeta-secretase 1Homo sapiens (human)
synaptic vesicleBeta-secretase 1Homo sapiens (human)
cell surfaceBeta-secretase 1Homo sapiens (human)
endosome membraneBeta-secretase 1Homo sapiens (human)
membraneBeta-secretase 1Homo sapiens (human)
axonBeta-secretase 1Homo sapiens (human)
dendriteBeta-secretase 1Homo sapiens (human)
neuronal cell bodyBeta-secretase 1Homo sapiens (human)
membrane raftBeta-secretase 1Homo sapiens (human)
recycling endosomeBeta-secretase 1Homo sapiens (human)
Golgi-associated vesicle lumenBeta-secretase 1Homo sapiens (human)
hippocampal mossy fiber to CA3 synapseBeta-secretase 1Homo sapiens (human)
endosomeBeta-secretase 1Homo sapiens (human)
plasma membraneBeta-secretase 1Homo sapiens (human)
trans-Golgi networkBeta-secretase 1Homo sapiens (human)
nucleusInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
nucleoplasmInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
cytoplasmInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
mitochondrionInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
mitochondrial outer membraneInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
cytosolInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
membraneInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
Bcl-2 family protein complexInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
mitochondrial outer membraneInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (42)

Assay IDTitleYearJournalArticle
AID338725Toxicity in brine shrimp
AID479389Cytotoxicity against human A549 cells after 48 hrs by resazurin reduction assay2010Bioorganic & medicinal chemistry, May-15, Volume: 18, Issue:10
In vitro cytotoxic activity of isolated acridones alkaloids from Zanthoxylum leprieurii Guill. et Perr.
AID338973Antitumor activity against Agrobacterium tumefaciens-induced crown gall tumor in potato tubers by potato disk assay
AID125225Inhibition of hamster liver mitochondrial monoamine oxidase MAO2001Journal of medicinal chemistry, Sep-27, Volume: 44, Issue:20
Synthesis of potential antidipsotropic isoflavones: inhibitors of the mitochondrial monoamine oxidase-aldehyde dehydrogenase pathway.
AID1272068Antimicrobial activity against Bacillus subtilis after 48 hrs by paper disk diffusion assay2016Bioorganic & medicinal chemistry letters, Jan-15, Volume: 26, Issue:2
Oxidative burst inhibition, cytotoxicity and antibacterial acriquinoline alkaloids from Citrus reticulate (Blanco).
AID715795Induction of apoptosis in human U937 cells assessed as reduction of normal cells at 500 uM after 24 hrs by Annexin V-FITC double staining2012Bioorganic & medicinal chemistry, Sep-15, Volume: 20, Issue:18
Structure-anti-leukemic activity relationship study of ortho-dihydroxycoumarins in U-937 cells: key role of the δ-lactone ring in determining differentiation-inducing potency and selective pro-apoptotic action.
AID715802Cytotoxicity against human U937 cells after 48 hrs by trypan blue assay2012Bioorganic & medicinal chemistry, Sep-15, Volume: 20, Issue:18
Structure-anti-leukemic activity relationship study of ortho-dihydroxycoumarins in U-937 cells: key role of the δ-lactone ring in determining differentiation-inducing potency and selective pro-apoptotic action.
AID311335Antiinflammatory activity in human neutrophils assessed as fMLP-induced superoxide release after 5 mins by spectrometry2007Journal of natural products, Sep, Volume: 70, Issue:9
New phenylpropenoids, bis(1-phenylethyl)phenols, bisquinolinone alkaloid, and anti-inflammatory constituents from Zanthoxylum integrifoliolum.
AID328636Antiinflammatory activity in human neutrophils assessed as inhibition of formyl-L-methionyl-L-leucyl-L-phenylalanine/cytochalasin B-induced elastase release2008Journal of natural products, Feb, Volume: 71, Issue:2
Neolignans, a coumarinolignan, lignan derivatives, and a chromene: anti-inflammatory constituents from Zanthoxylum avicennae.
AID1272074Antimicrobial activity against Pythium ultimum after 48 hrs by paper disk diffusion assay2016Bioorganic & medicinal chemistry letters, Jan-15, Volume: 26, Issue:2
Oxidative burst inhibition, cytotoxicity and antibacterial acriquinoline alkaloids from Citrus reticulate (Blanco).
AID1138893Antiasthamic activity in Wistar rat tracheal ring assessed as reversal of carbachol-induced contraction at 0.1 to 500 uM relative to control2014European journal of medicinal chemistry, Apr-22, Volume: 77Semisynthesis, ex vivo evaluation, and SAR studies of coumarin derivatives as potential antiasthmatic drugs.
AID1701173Displacement of FAM-Bid peptide from recombinant N-terminal His6x-tagged human Mcl-1 expressed in Escherichia coli BL21 (DE3) incubated for 30 mins by fluorescence polarization assay2021Bioorganic & medicinal chemistry, 01-01, Volume: 29Synthesis and structure-activity relationship of coumarins as potent Mcl-1 inhibitors for cancer treatment.
AID422001Antiinflammatory activity in human neutrophils assessed as inhibition of fMet-Leu-Phe/Cytochalasin B-induced superoxide anion generation treated 5 mins before fMet-Leu-Phe/Cytochalasin B challenge by spectrophotometry2009Journal of natural products, Feb-27, Volume: 72, Issue:2
Benzophenone derivatives from the fruits of Garcinia multiflora and their anti-inflammatory activity.
AID1272072Antimicrobial activity against Candida albicans after 48 hrs by paper disk diffusion assay2016Bioorganic & medicinal chemistry letters, Jan-15, Volume: 26, Issue:2
Oxidative burst inhibition, cytotoxicity and antibacterial acriquinoline alkaloids from Citrus reticulate (Blanco).
AID715803Antiproliferative activity against human U937 cells assessed as incorporation of [3H]-methyl-thymidine after 12 hrs by scintillation counting2012Bioorganic & medicinal chemistry, Sep-15, Volume: 20, Issue:18
Structure-anti-leukemic activity relationship study of ortho-dihydroxycoumarins in U-937 cells: key role of the δ-lactone ring in determining differentiation-inducing potency and selective pro-apoptotic action.
AID479391Cytotoxicity against human WS1 cells after 48 hrs by resazurin reduction assay2010Bioorganic & medicinal chemistry, May-15, Volume: 18, Issue:10
In vitro cytotoxic activity of isolated acridones alkaloids from Zanthoxylum leprieurii Guill. et Perr.
AID1272073Antimicrobial activity against Aphanomyces cochlioides after 48 hrs by paper disk diffusion assay2016Bioorganic & medicinal chemistry letters, Jan-15, Volume: 26, Issue:2
Oxidative burst inhibition, cytotoxicity and antibacterial acriquinoline alkaloids from Citrus reticulate (Blanco).
AID328635Antiinflammatory activity in human neutrophils assessed as inhibition of formyl-L-methionyl-L-leucyl-L-phenylalanine/cytochalasin B-induced superoxide anion generation2008Journal of natural products, Feb, Volume: 71, Issue:2
Neolignans, a coumarinolignan, lignan derivatives, and a chromene: anti-inflammatory constituents from Zanthoxylum avicennae.
AID637775Inhibition of recombinant human BACE1 using Rh-EVNLDAEFK as substrate at 500 uM after 60 mins by fluorescence quenching assay2012Bioorganic & medicinal chemistry, Jan-15, Volume: 20, Issue:2
Structure-activity relationships for naturally occurring coumarins as β-secretase inhibitor.
AID1272075Antimicrobial activity against Rhizoctonia solani after 48 hrs by paper disk diffusion assay2016Bioorganic & medicinal chemistry letters, Jan-15, Volume: 26, Issue:2
Oxidative burst inhibition, cytotoxicity and antibacterial acriquinoline alkaloids from Citrus reticulate (Blanco).
AID1272069Antimicrobial activity against Staphylococcus aureus after 48 hrs by paper disk diffusion assay2016Bioorganic & medicinal chemistry letters, Jan-15, Volume: 26, Issue:2
Oxidative burst inhibition, cytotoxicity and antibacterial acriquinoline alkaloids from Citrus reticulate (Blanco).
AID423017Antiinflammatory activity against human neutrophils assessed as inhibition of fMLP/CB-induced superoxide anion generation2009Journal of natural products, Jan, Volume: 72, Issue:1
Amides and benzenoids from Zanthoxylum ailanthoides with inhibitory activity on superoxide generation and elastase release by neutrophils.
AID479390Cytotoxicity against human DLD1 cells after 48 hrs by resazurin reduction assay2010Bioorganic & medicinal chemistry, May-15, Volume: 18, Issue:10
In vitro cytotoxic activity of isolated acridones alkaloids from Zanthoxylum leprieurii Guill. et Perr.
AID390887Antiinflammatory activity in human neutrophils assessed as inhibition of fMLP/cytochalasin B-induced superoxide radical anion generation2008Journal of natural products, Oct, Volume: 71, Issue:10
Phthalides from Pittosporum illicioides var. illicioides with inhibitory activity on superoxide generation and elastase release by neutrophils.
AID423019Antiinflammatory activity against human neutrophils assessed as inhibition of fMLP/CB-induced elastase release at 10 ug/ml2009Journal of natural products, Jan, Volume: 72, Issue:1
Amides and benzenoids from Zanthoxylum ailanthoides with inhibitory activity on superoxide generation and elastase release by neutrophils.
AID637774Inhibition of recombinant human BACE1 using Rh-EVNLDAEFK as substrate after 60 mins by fluorescence quenching assay2012Bioorganic & medicinal chemistry, Jan-15, Volume: 20, Issue:2
Structure-activity relationships for naturally occurring coumarins as β-secretase inhibitor.
AID405575Antitubercular activity against Mycobacterium tuberculosis H37Rv after 2 weeks by agar dilution method2008Journal of natural products, Jun, Volume: 71, Issue:6
Dihydroagarofuranoid sesquiterpenes, a lignan derivative, a benzenoid, and antitubercular constituents from the stem of Microtropis japonica.
AID1852251Inhibition of Clostridium histolyticum CoLH using M MOCAcPro-Leu-Gly-Leu-A2pr-(DNP)Ala-Arg-NH2 as substrate incubated for 10 mins by fluorescence spectrophotometer analysis2022Journal of medicinal chemistry, 10-13, Volume: 65, Issue:19
Discovery and Characterization of Synthesized and FDA-Approved Inhibitors of Clostridial and Bacillary Collagenases.
AID390888Antiinflammatory activity in human neutrophils assessed as inhibition of fMLP/Cytochalasin B-induced elastase release2008Journal of natural products, Oct, Volume: 71, Issue:10
Phthalides from Pittosporum illicioides var. illicioides with inhibitory activity on superoxide generation and elastase release by neutrophils.
AID422002Antiinflammatory activity in human neutrophils assessed as inhibition of fMet-Leu-Phe/Cytochalasin B-induced elastase release treated 5 mins before fMet-Leu-Phe/Cytochalasin B challenge2009Journal of natural products, Feb-27, Volume: 72, Issue:2
Benzophenone derivatives from the fruits of Garcinia multiflora and their anti-inflammatory activity.
AID1138894Antiasthamic activity in Wistar rat tracheal ring assessed as reversal of carbachol-induced contraction2014European journal of medicinal chemistry, Apr-22, Volume: 77Semisynthesis, ex vivo evaluation, and SAR studies of coumarin derivatives as potential antiasthmatic drugs.
AID1546503Antiproliferative activity against human HL60 cells assessed as reduction in cell viability after 3 days by XTT assay2020Bioorganic & medicinal chemistry, 01-01, Volume: 28, Issue:1
Artemisia: a promising plant for the treatment of cancer.
AID1272066Inhibition of serum-opsonized zymosan-induced oxidative burst in whole blood (unknown origin)2016Bioorganic & medicinal chemistry letters, Jan-15, Volume: 26, Issue:2
Oxidative burst inhibition, cytotoxicity and antibacterial acriquinoline alkaloids from Citrus reticulate (Blanco).
AID34048Inhibition of hamster liver aldehyde dehydrogenase ALDH-2; No inhibition uM2001Journal of medicinal chemistry, Sep-27, Volume: 44, Issue:20
Synthesis of potential antidipsotropic isoflavones: inhibitors of the mitochondrial monoamine oxidase-aldehyde dehydrogenase pathway.
AID338971Cytotoxicity against human 9KB cells
AID1272067Cytotoxicity against human PC3 cells after 3 days by MTT assay2016Bioorganic & medicinal chemistry letters, Jan-15, Volume: 26, Issue:2
Oxidative burst inhibition, cytotoxicity and antibacterial acriquinoline alkaloids from Citrus reticulate (Blanco).
AID1272071Antimicrobial activity against Mucor miehei after 48 hrs by paper disk diffusion assay2016Bioorganic & medicinal chemistry letters, Jan-15, Volume: 26, Issue:2
Oxidative burst inhibition, cytotoxicity and antibacterial acriquinoline alkaloids from Citrus reticulate (Blanco).
AID715776Pro-oxidant activity in 0.1 M potassium phosphate buffer at pH 7.4 assessed as increase of oxidation potential by cyclic voltammetry analysis2012Bioorganic & medicinal chemistry, Sep-15, Volume: 20, Issue:18
Structure-anti-leukemic activity relationship study of ortho-dihydroxycoumarins in U-937 cells: key role of the δ-lactone ring in determining differentiation-inducing potency and selective pro-apoptotic action.
AID1272070Antimicrobial activity against Escherichia coli after 48 hrs by paper disk diffusion assay2016Bioorganic & medicinal chemistry letters, Jan-15, Volume: 26, Issue:2
Oxidative burst inhibition, cytotoxicity and antibacterial acriquinoline alkaloids from Citrus reticulate (Blanco).
AID715793Induction of apoptosis in human U937 cells assessed as activation of caspase-3 at 500 uM after 24 hrs by colorimetric assay2012Bioorganic & medicinal chemistry, Sep-15, Volume: 20, Issue:18
Structure-anti-leukemic activity relationship study of ortho-dihydroxycoumarins in U-937 cells: key role of the δ-lactone ring in determining differentiation-inducing potency and selective pro-apoptotic action.
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (162)

TimeframeStudies, This Drug (%)All Drugs %
pre-199018 (11.11)18.7374
1990's20 (12.35)18.2507
2000's36 (22.22)29.6817
2010's66 (40.74)24.3611
2020's22 (13.58)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 28.09

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index28.09 (24.57)
Research Supply Index5.12 (2.92)
Research Growth Index4.86 (4.65)
Search Engine Demand Index36.71 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (28.09)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews3 (1.80%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other164 (98.20%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]